Biogen Inc. buy Haans
Start price
24.10.16
/
50%
€261.98
Target price
24.04.17
€288.64
Performance (%)
3.34%
End price
24.04.17
€250.39
Summary
This prediction ended on 24.04.17 with a price of €250.39. With a performance of 3.34%, the BUY prediction by Haans for Biogen Inc. closed with a slight gain. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 3.903% | 3.903% | 24.144% | -36.580% |
| iShares Core DAX® | 0.193% | -1.216% | 8.843% | 58.517% |
| iShares Nasdaq 100 | -1.353% | -5.307% | -1.141% | 82.228% |
| iShares Nikkei 225® | -0.426% | 7.319% | 27.580% | 65.208% |
| iShares S&P 500 | -1.008% | -3.400% | -0.222% | 56.665% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Biotech muss man nicht haben, aber man sollte...
Das Aufwärtsgap , von Ende Juli, wurde geschlossen, jetzt kann es wieder Richtung Norden gehen.
(Laufzeit überschritten)


